INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY WORLD HEALTH ORGANIZATION TOXICOLOGICAL EVALUATION OF SOME FOOD COLOURS, EMULSIFIERS, STABILIZERS, ANTI-CAKING AGENTS AND CERTAIN OTHER SUBSTANCES FAO Nutrition Meetings Report Series No. 46A WHO/FOOD ADD/70.36 The content of this document is the result of the deliberations of the Joint FAO/WHO Expert Committee on Food Additives which met in Rome, 27 May - 4 June 19691 Food and Agriculture Organization of the United Nations World Health Organization 1 Thirteenth report of the Joint FAO/WHO Expert Committee on Food Additives, FAO Nutrition Meetings Report Series, in press; Wld Hlth Org. techn. Rep. Ser., in press. SALTS OF MYRISTIC, PALMITIC AND STEARIC ACID WITH BASES ACCEPTED FOR FOOD USE Biological Data Biochemical aspects Myristic, Palmitic and Stearic acid is the naturally occurring fatty acid component of tallow and other animal fats and oils as well as some vegetable oils. Most of the commercial and pharmaceutical preparations also contain mixed acids. Myristic acid has been shown to decrease the incorporation of acetyl Co A into fatty acids by liver homogluates. (Korchak & Masoro 1964). Giving 1-C14 labelled stearic acid to two groups of four male rats resulted in the formation of labelled cholesterol which was widely distributed within 24 hours after administration (De Leo & Foti 1961). Diets containing 20-40 per cent. glycerylmonostearate depress the growth and cause high mortality in young and adult mice. This is preventable by four per cent. oleate or linoleate. Depot fat levels of stearate do not increase. The mechanism of toxicity is unknown (Tove 1964). Stearic acid is only 24 per cent. digestible as measured by fat ingested and excreted in male rats fed seven to eight days 10 per cent. of stearic acid in their diet (Carroll & Richards 1958). Stearic acid decreases the incorporation of acetyl Co A into fatty acids by liver homogenate fractions (Korchak & Masoro 1964). Comments Myristic, palmitic and stearic acid and their salts are normal products of the metabolism of fats and their metabolic fate is well established. Provided the contribution of the actions does not add excessively to the normal body load there is not need to consider the use of these substances as hazardous in any way. EVALUATION Not limited except for good manufacturing practice. REFERENCES Carroll, K. K. & Richards, J. F, (1958) J. Nutr., 64, 411 De Leo, T. & Foti, L. (1961) Drugs affecting Lipid Metabolism Proc. Symp. Milano, 83-88 Korchak, H. M. & Masoro, E. J. (1964) Biochim. biophys. Acta., 84, 750 Tove, S. B. (1964) J. Nutr., 84, 237
See Also: Toxicological Abbreviations